Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-28T15:47:18.418Z Has data issue: false hasContentIssue false

Innovations in treatment of psychosis in southeast europe

Published online by Cambridge University Press:  19 July 2023

N. Jovanovic*
Affiliation:
Queen Mary University of London, London, United Kingdom

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Southeast Europe (SEE) is home to 70 million people living across 12 countries. These countries share similar socioeconomic background and tradition of healthcare systems, although many differences exist in the organisation of mental health care. The region has been called ‘the blind spot on the global mental health map’ due to lack of research and innovations in mental health care. In recent years European Commission has invested significant resources to improve mental health care of individuals with severe mental disorders in Southeast Europe. Two major, recently completed, projects are Recover-e and Impulse. This presentation will focus on findings from the Impulse study. We will start with an overview of evidence-based, non-pharmacological interventions for individuals with psychosis, with focus on what is offered and implemented in 12 SEE countries. Next, we will present key findings from the hybrid type II effectiveness-implementation psychosocial randomised-controlled trial. We will show an evidence-based approach how to improve psychosocial aspect of treatment of individuals with psychotic disorders. Mental health services that offer a combined-therapy approach, including psychosocial interventions and pharmacotherapy, can ensure holistic care, preferred by patients and their families. Discussion will include the role of implementation science tool in mental health care and sustainability of implemented interventions.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.